TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -4 | -8 | 5 | 8 | 4 | 20 | 4 |
| S | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/10 13:10 | 9/3/10 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Lynch Thomas J | NC | O | SVP,Corp | S.a | -2,968 | 22.50 | 0 | -132 | -98 | 3 | D | ||||||||||||||
9/7/10 16:30 | 9/3/10 | V | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Lynch Thomas J | NC | O | SVP,Corp | S | -2,552 | 22.50 | 33 | -113 | -84 | 21 | D | 4 | 3 | -20 | 1 | -5 | 0 | 2 | 5 | -4 | -8 | 5 | 8 | 4 | 20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |